Is InMode’s CEO Trying To Buy The Company Too Cheap?

InMode Ltd. has suddenly become one of the more intriguing takeover stories in medtech after confirming an unsolicited $16.20-per-share offer from M.N. Business Strategy, a group backed by CEO and co-founder Moshe Mizrahy. The timing is what makes the situation especially interesting. The company is coming off a difficult 2025, including a failed sale process, but its latest earnings call pointed to early signs of stabilization, especially in North America. Revenue returned to growth, cash remains substantial, and buybacks have continued aggressively. At the same time, margins are under pressure, competition in aesthetics is rising, and management itself has acknowledged that the industry is changing.